Literature DB >> 22821918

Diffusion tensor imaging correlates with the clinical assessment of disease severity in cervical spondylotic myelopathy and predicts outcome following surgery.

J G A Jones1, S Y Cen, R M Lebel, P C Hsieh, M Law.   

Abstract

BACKGROUND AND
PURPOSE: CSM is a common neurologic disease that results in progressive disability and eventual paralysis without appropriate treatment. Imaging plays a significant role in the evaluation of CSM and has evolved with recent technical advances. We sought to systematically explore the relationship between clinical disease severity and DTI in CSM, and to investigate the potential use of DTI in surgical decision-making models.
MATERIALS AND METHODS: MR imaging studies and clinical assessments were prospectively collected on 30 patients with CSM. Spearman correlations were used to investigate associations between clinical disease severity and FA at the time of diagnosis. Clinical assessment was performed using mJOA, Nurick, Short Form-36, and NDI scores. Fifteen patients with CSM subsequently underwent decompressive surgery; Spearman correlation and logistic regression were applied to this cohort to study the relationship between baseline DTI measurements and postoperative outcome. Conventional imaging (spinal cord T2 signal intensity and degree of stenosis) was evaluated for comparison with DTI.
RESULTS: At diagnosis, FA demonstrated a strong correlation with baseline mJOA (r = 0.62, P < .01) and Nurick (r = -0.46, P = .01) scores. After surgery, recovery of function demonstrated by improvement in NDI score was associated with higher FA values on preoperative DTI (r = -0.61, P = .04). Severely affected patients with CSM with disproportionately high FA tended to achieve greater mJOA scores after surgery compared with subjects with lower FA (P = .08). T2 signal intensity was associated with functional status at baseline but did not predict postoperative outcome; degree of stenosis lacked any significant correlation with clinical parameters.
CONCLUSIONS: DTI may be a useful diagnostic tool for assessing disease severity in CSM. The predictive value of DTI regarding postoperative outcome may improve surgical decision-making and facilitate health care outcomes research.

Entities:  

Mesh:

Year:  2012        PMID: 22821918      PMCID: PMC7965104          DOI: 10.3174/ajnr.A3199

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  Diffusion tensor imaging and fibre tracking in cervical spondylotic myelopathy.

Authors:  Jean-François Budzik; Vincent Balbi; Vianney Le Thuc; Alain Duhamel; Richard Assaker; Anne Cotten
Journal:  Eur Radiol       Date:  2010-08-20       Impact factor: 5.315

2.  Abnormal magnetic-resonance scans of the cervical spine in asymptomatic subjects. A prospective investigation.

Authors:  S D Boden; P R McCowin; D O Davis; T S Dina; A S Mark; S Wiesel
Journal:  J Bone Joint Surg Am       Date:  1990-09       Impact factor: 5.284

3.  New MRI grading system for the cervical canal stenosis.

Authors:  Yusuhn Kang; Joon Woo Lee; Young Hwan Koh; Saebeom Hur; Su Jin Kim; Jee Won Chai; Heung Sik Kang
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

4.  The pathogenesis of the spinal cord disorder associated with cervical spondylosis.

Authors:  S Nurick
Journal:  Brain       Date:  1972       Impact factor: 13.501

Review 5.  Cervical spondylotic myelopathy.

Authors:  M Bernhardt; R A Hynes; H W Blume; A A White
Journal:  J Bone Joint Surg Am       Date:  1993-01       Impact factor: 5.284

6.  Validity and reliability of the Short Form-36 in cervical spondylotic myelopathy.

Authors:  Joseph T King; Mark S Roberts
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

7.  Pathogenesis of cervical spondylotic myelopathy.

Authors:  D N Levine
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

8.  Cervical laminectomy and dentate ligament section for cervical spondylotic myelopathy.

Authors:  E C Benzel; J Lancon; L Kesterson; T Hadden
Journal:  J Spinal Disord       Date:  1991-09

9.  Quality of life assessment with the medical outcomes study short form-36 among patients with cervical spondylotic myelopathy.

Authors:  Joseph T King; Kathleen A McGinnis; Mark S Roberts
Journal:  Neurosurgery       Date:  2003-01       Impact factor: 4.654

10.  Retrograde Wallerian degeneration of cranial corticospinal tracts in cervical spinal cord injury patients using diffusion tensor imaging.

Authors:  Saurabh Guleria; Rakesh K Gupta; Sona Saksena; Anil Chandra; R N Srivastava; Mazhar Husain; Ramkishore Rathore; Ponnada A Narayana
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

View more
  56 in total

1.  Use of Spinal Cord Diffusion Tensor Imaging to Quantify Neural Ablation and Evaluate Outcome after Percutaneous Cordotomy for Intractable Cancer Pain.

Authors:  Aditya Vedantam; Ping Hou; T Linda Chi; Patrick M Dougherty; Kenneth R Hess; Ashwin Viswanathan
Journal:  Stereotact Funct Neurosurg       Date:  2017-01-14       Impact factor: 1.875

2.  Quantitative assessment of column-specific degeneration in cervical spondylotic myelopathy based on diffusion tensor tractography.

Authors:  Jiao-Long Cui; Xiang Li; Tin-Yan Chan; Kin-Cheung Mak; Keith Dip-Kei Luk; Yong Hu
Journal:  Eur Spine J       Date:  2014-08-24       Impact factor: 3.134

3.  Diffusion tensor imaging predicts functional impairment in mild-to-moderate cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; John W Grinstead; Langston T Holly
Journal:  Spine J       Date:  2014-02-20       Impact factor: 4.166

4.  The evaluation on neural status of cervical spinal cord in normal and Hirayama disease using diffusion tensor imaging.

Authors:  Chi Sun; Shuyi Zhou; Zhongyi Cui; Yuxuan Zhang; Hongli Wang; Jianyuan Jiang; Feizhou Lu; Xiaosheng Ma
Journal:  Eur Spine J       Date:  2019-05-20       Impact factor: 3.134

5.  Predictive value of flexion and extension diffusion tensor imaging in the early stage of cervical myelopathy.

Authors:  Tomasz Tykocki; Philip English; David Minks; Arunkumar Krishnakumar; Guy Wynne-Jones
Journal:  Neuroradiology       Date:  2018-09-19       Impact factor: 2.804

6.  A Novel MRI Biomarker of Spinal Cord White Matter Injury: T2*-Weighted White Matter to Gray Matter Signal Intensity Ratio.

Authors:  A R Martin; B De Leener; J Cohen-Adad; D W Cadotte; S Kalsi-Ryan; S F Lange; L Tetreault; A Nouri; A Crawley; D J Mikulis; H Ginsberg; M G Fehlings
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-20       Impact factor: 3.825

7.  Reproducibility, temporal stability, and functional correlation of diffusion MR measurements within the spinal cord in patients with asymptomatic cervical stenosis or cervical myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Davis C Woodworth; Hajime Yokota; Langston T Holly
Journal:  J Neurosurg Spine       Date:  2018-02-09

8.  Diffusion tensor imaging can predict surgical outcomes of patients with cervical compression myelopathy.

Authors:  Satoshi Maki; Masao Koda; Mitsuhiro Kitamura; Taigo Inada; Koshiro Kamiya; Mitsutoshi Ota; Yasushi Iijima; Junya Saito; Yoshitada Masuda; Koji Matsumoto; Masatoshi Kojima; Takayuki Obata; Kazuhisa Takahashi; Masashi Yamazaki; Takeo Furuya
Journal:  Eur Spine J       Date:  2017-06-16       Impact factor: 3.134

9.  Correlation between degree of subvoxel spinal cord compression measured with super-resolution tract density imaging and neurological impairment in cervical spondylotic myelopathy.

Authors:  Benjamin M Ellingson; Noriko Salamon; Davis C Woodworth; Langston T Holly
Journal:  J Neurosurg Spine       Date:  2015-03-06

10.  Magnetic Resonance Imaging Biomarker of Axon Loss Reflects Cervical Spondylotic Myelopathy Severity.

Authors:  Rory K J Murphy; Peng Sun; Junqian Xu; Yong Wang; Samir Sullivan; Paul Gamble; Joanne Wagner; Neill N Wright; Ian G Dorward; Daniel Riew; Paul Santiago; Michael P Kelly; Kathryn Trinkaus; Wilson Z Ray; Sheng-Kwei Song
Journal:  Spine (Phila Pa 1976)       Date:  2016-05       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.